SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-002295
Filing Date
2010-03-16
Accepted
2010-03-16 15:58:21
Documents
9
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2197312z10-k.htm 10-K 1084945
2 EXHIBIT 10.21 a2197312zex-10_21.htm EX-10.21 72288
3 EXHIBIT 23.1 a2197312zex-23_1.htm EX-23.1 2905
4 EXHIBIT 23.2 a2197312zex-23_2.htm EX-23.2 3212
5 EXHIBIT 31.1 a2197312zex-31_1.htm EX-31.1 7198
6 EXHIBIT 31.2 a2197312zex-31_2.htm EX-31.2 7237
7 EXHIBIT 32.1 a2197312zex-32_1.htm EX-32.1 3536
8 EXHIBIT 32.2 a2197312zex-32_2.htm EX-32.2 3574
9 G564284.JPG g564284.jpg GRAPHIC 49709
  Complete submission text file 0001047469-10-002295.txt   1255063
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16614 | Film No.: 10685545
SIC: 2834 Pharmaceutical Preparations